Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Color Vision Defects × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 268 Carcinoma, Non-Small-Cell Lung 205 Neoplasms 188 Prostatic Neoplasms 155 Neoplasm Metastasis 120 Multiple Myeloma 119 Lung Neoplasms 102 Melanoma 100 Colorectal Neoplasms 100 Leukemia, Myeloid, Acute 99 Lymphoma 82 Ovarian Neoplasms 77 Lymphoma, Non-Hodgkin 70 Leukemia, Lymphocytic, Chronic, B-Cell 68 Pancreatic Neoplasms 65 Squamous Cell Carcinoma of Head and Neck 62 Myelodysplastic Syndromes 59 Hematologic Neoplasms 59 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Glioblastoma 56 Brain Neoplasms 53 Triple Negative Breast Neoplasms 52 Parkinson Disease 4, Autosomal Dominant Lewy Body 52 Recurrence 51 Leukemia 51 Head and Neck Neoplasms 49 Lymphoma, Follicular 45 Carcinoma, Hepatocellular 45 Colonic Neoplasms 44 Urinary Bladder Neoplasms 41

Interventions

Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05774197 2025-11-04

STAMP+CBT

University of Oklahoma

Phase NA Completed

52 enrolled 7 charts

Cancer Pain, Color Vision Defects

Data powered by HemOnc (CC BY 4.0) Colophon ⚡